{"id":"https://openalex.org/W4283323894","doi":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","title":"P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA","display_name":"P847: MRD BY MASS SPECTROMETRY IN PERIPHERAL BLOOD AND NEXT GENERATION SEQUENCING IN BONE MARROW IN A PHASE 2 STUDY OF DARATUMUMAB, CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283323894","doi":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000846272.91489.2d","doi":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058665273","display_name":"Benjamin Avi Derman","orcid":"https://orcid.org/0000-0002-4070-1819","observed_orcids":["https://orcid.org/0000-0002-4070-1819"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"B. Derman","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Rosenblatt","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Avigan","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069593908","display_name":"Ajay Major","orcid":"https://orcid.org/0000-0001-7261-1335","observed_orcids":["https://orcid.org/0000-0001-7261-1335"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Major","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091316016","display_name":"Murtuza M. Rampurwala","orcid":"https://orcid.org/0000-0002-2825-186X","observed_orcids":["https://orcid.org/0000-0002-2825-186X"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Rampurwala","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006847890","display_name":"David R. Barnidge","orcid":"https://orcid.org/0000-0002-3314-8293","observed_orcids":["https://orcid.org/0000-0002-3314-8293"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Barnidge","raw_affiliation_strings":["The Binding Site Group, Rochester, MN, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Binding Site Group, Rochester, MN, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088800372","display_name":"Andrew T. Stefka","orcid":"https://orcid.org/0000-0002-7651-3430","observed_orcids":["https://orcid.org/0000-0002-7651-3430"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Stefka","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111829561","display_name":"K. Jiang","orcid":"https://orcid.org/0000-0002-3777-5411","observed_orcids":["https://orcid.org/0000-0002-3777-5411"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Jiang","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057911528","display_name":"Andrzej J. Jakubowiak","orcid":"https://orcid.org/0000-0002-2597-6822","observed_orcids":["https://orcid.org/0000-0002-2597-6822"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Jakubowiak","raw_affiliation_strings":["Section of Hematology/Oncology, University of Chicago, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Hematology/Oncology, University of Chicago, Chicago","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5058665273"],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09118285,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"741","last_page":"742"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9580000042915344},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mass-spectrometry","display_name":"mass spectrometry","score":0.8799999952316284},{"id":"https://openalex.org/keywords/peripheral-blood","display_name":"peripheral blood","score":0.5870000123977661},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.8640000224113464},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.8109999895095825},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.8880000114440918},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/assay-concordance","display_name":"assay concordance","score":0.6650000214576721},{"id":"https://openalex.org/keywords/clonoseq","display_name":"clonoSEQ","score":0.5759999752044678},{"id":"https://openalex.org/keywords/maldi-tof-mass-spectrometry","display_name":"MALDI-TOF mass spectrometry","score":0.9210000038146973},{"id":"https://openalex.org/keywords/liquid-chromatography-mass-spectrometry","display_name":"liquid chromatography-mass spectrometry","score":0.8989999890327454},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.7799999713897705},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6389999985694885},{"id":"https://openalex.org/keywords/minimal-residual-disease-detection","display_name":"minimal residual disease detection","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7611709833145142},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.722163200378418},{"id":"https://openalex.org/C2781119759","wikidata":"https://www.wikidata.org/wiki/Q5222113","display_name":"Daratumumab","level":4,"score":0.7173159718513489},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6894883513450623},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5513203740119934},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5255357623100281},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5165802240371704},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5015339851379395},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.493988573551178}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000846272.91489.2d","doi":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9430627","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9430627","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c0186e60bf9c4631bb6f2e63822db9da","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c0186e60bf9c4631bb6f2e63822db9da","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 741-742 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000846272.91489.2d","doi":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000846272.91489.2d","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3032057617","https://openalex.org/W3206476260","https://openalex.org/W3171369895","https://openalex.org/W4399140582","https://openalex.org/W3116906611","https://openalex.org/W4417014829","https://openalex.org/W2981157998","https://openalex.org/W4389233351","https://openalex.org/W4410989410","https://openalex.org/W3032595940"],"abstract_inverted_index":{"Background:":[0],"Measurable":[1],"residual":[2],"disease":[3],"(MRD)":[4],"as":[5],"assessed":[6,31,163],"by":[7,106,111,160,167,180,193,395,464,503,525],"next":[8],"generation":[9],"sequencing":[10],"(NGS)":[11],"using":[12,184],"bone":[13],"marrow":[14],"(BM)":[15],"aspirate":[16,50],"carries":[17],"prognostic":[18,443,536],"significance":[19,444,537],"in":[20,95,108,113,143,469,473,479,527],"multiple":[21],"myeloma":[22],"(MM).":[23],"Though":[24],"its":[25],"analytical":[26],"sensitivity":[27,500,507,522,531],"reaches":[28],"10-6,":[29],"MRD":[30,68,105,159,179,462,502,524],"from":[32,121,164,333,418,492,513],"BM":[33,109,165,205,474,528],"may":[34,63,483],"be":[35,452],"vulnerable":[36],"to":[37,41,48,247,312,326,397,409,488,495,516],"false":[38,485],"negatives":[39],"due":[40,47,487],"patchy":[42],"or":[43,46,437,448],"extramedullary":[44],"disease,":[45],"inadequate":[49],"sample.":[51],"Mass":[52],"spectrometry":[53],"(MS)":[54],"is":[55,542],"a":[56,174,334,419,506,530],"promising":[57],"peripheral":[58],"blood":[59],"(PB)":[60],"assay":[61,170],"that":[62],"approximate":[64,498],"current":[65],"methods":[66],"of":[67,81,104,141,176,307,390,412,429,445,501,509,523,533,538],"detection.":[69],"Aims:":[70],"In":[71],"this":[72,128,455],"phase":[73,129],"2":[74,130],"study":[75,131],"evaluating":[76,101],"the":[77,102,168,194,257,295,342,377,413,499,521],"safety":[78],"and":[79,86,110,190,204,217,234,252,271,282,284,292,300,353,364,366,371,382,388,457,467,471,518,544],"efficacy":[80],"extended":[82],"daratumumab,":[83],"carfilzomib,":[84],"lenalidomide,":[85],"dexamethasone":[87],"(Dara-KRd)":[88],"without":[89,146],"autologous":[90],"stem":[91,150],"cell":[92,151],"transplant":[93],"(ASCT)":[94],"newly":[96],"diagnosed":[97],"MM,":[98],"we":[99],"are":[100],"concordance":[103,249,350],"NGS":[107,161,206,253,267,281,291,299,352,363,370,381,472,504,526],"MS":[112,181,203,251,465,481],"PB.":[114],"Methods:":[115],"Forty-one":[116],"patients":[117,137,212,219,310,450],"have":[118,433],"been":[119,434],"enrolled":[120],"two":[122],"MM":[123],"Research":[124],"Consortium":[125],"sites":[126],"into":[127],"(planned":[132],"enrollment":[133],"45":[134],"patients).":[135],"All":[136],"receive":[138],"24":[139],"cycles":[140,145],"Dara-KRd":[142],"28-day":[144],"ASCT.":[147],"With":[148,426],"optional":[149],"collection":[152],"for":[153,210,298,380],"ASCT-eligible":[154],"candidates":[155],"after":[156],"cycle":[157],"4.":[158],"was":[162,182,245,263,274,332,348,356,393],"aspirates":[166],"clonoSEQ\u00ae":[169],"(Adaptive":[171],"Biotechnologies)":[172],"with":[173,336,421],"limit":[175],"detection":[177],"<10-6.":[178],"evaluated":[183],"both":[185],"an":[186],"automated":[187],"MALDI-TOF":[188],"(EXENT)":[189],"liquid-chromatography-MS":[191],"(LC-MS)":[192],"Binding":[195],"Site":[196],"Group":[197],"(assays":[198],"under":[199],"development).":[200],"Paired":[201],"PB":[202,470,493,514],"samples":[207,230,238],"were":[208,226,304,322,386,405,417],"available":[209],"13":[211],"at":[213,220,314,454,505,529],"early":[214,258],"(post-cycle":[215],"4)":[216,233],"18":[218],"later":[221,343],"(cycles":[222,345],"8-24)":[223],"timepoints.":[224],"There":[225,355],"44":[227],"paired":[228,236],"NGS/EXENT":[229],"(14":[231],"post-cycle":[232,240,259],"42":[235],"NGS/LC-MS":[237,318,401],"(13":[239],"4).":[241],"Cohen\u2019s":[242],"kappa":[243,278,288,337,360,374,422],"test":[244],"used":[246],"assess":[248],"between":[250,266,280,290,351,362,369],"samples.":[254],"Results:":[255],"For":[256,316,341,399],"4":[260,309],"timepoint,":[261],"there":[262,273,347,432],"low":[264],"agreement":[265,276,286,358,368],"(sensitivity":[268],"threshold":[269,508,532],"10-6)":[270],"MS;":[272],"46%":[275],"(Cohen\u2019s":[277,287,359,373],"-0.18)":[279],"EXENT":[283,365,491],"54%":[285],"-0.15)":[289],"LC-MS.":[293],"Of":[294,376],"discordant":[296,317,378,400],"cases":[297,379,392,416],"EXENT,":[301,383],"4/7":[302],"(57%)":[303],"NGS-/EXENT+.":[305],"Two":[306,411],"these":[308,391,440],"converted":[311,325,408],"EXENT-":[313],"C8.":[315],"cases,":[319,402],"5/6":[320],"(83%)":[321],"NGS-/LC-MS+.":[323,406],"None":[324,407],"LC-MS-.":[327,410],"The":[328,442,535],"one":[329],"NGS+/LC-MS-":[330],"case":[331],"patient":[335,420],"light":[338,423],"chain":[339,424],"MM.":[340,425],"timepoints":[344],"8-24),":[346],"higher":[349],"MS.":[354],"63%":[357],"0.27)":[361],"59%":[367],"LC-MS":[372,512,540],"0.13).":[375],"4/11":[384],"(36%)":[385],"NGS-/EXENT+":[387],"1":[389],"followed":[394],"conversion":[396],"EXENT-.":[398],"9/12":[403],"(75%)":[404],"three":[414],"NGS-/LC-MS+":[415],"median":[427],"follow-up":[428],"10":[430],"months,":[431],"no":[435],"progressions":[436],"deaths":[438],"among":[439],"patients.":[441],"persistent":[446,539],"NGS+":[447],"LC-MS+":[449],"cannot":[451],"determined":[453],"time":[456],"requires":[458,545],"longer":[459,546],"follow-up.":[460,547],"Image:Summary/Conclusion:":[461],"assessment":[463],"(EXENT":[466],"LC-MS)":[468],"serve":[475],"complementary":[476],"roles.":[477],"Early":[478],"treatment,":[480],"positivity":[482,541],"represent":[484],"positives":[486],"immunoglobulin":[489],"recycling.":[490],"appears":[494,515],"more":[496],"closely":[497],"10-5,":[510],"while":[511],"reach":[517],"possibly":[519],"exceed":[520],"10-6.":[534],"unclear":[543]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-06-24T00:00:00"}